Approval · Notice of Compliance 25341 · 2021
IRINOTECAN: Notice of Compliance 25341
Issued March 2, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25341
- Date
- March 2, 2021
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Labelling update to match licensor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IRINOTECAN | Not yet assigned | — |
Medicinal ingredients
- IRINOTECAN HYDROCHLORIDE 20 MG per ML